100 signatures reached
To: President Biden's Chief of Staff
President Biden keep your promise: Don't put pharma profits over billions of lives
Chief of Staff Ron Klain: the U.S. must support vaccine technology sharing
Why is this important?
Unless policies change, billions of people around the world, especially in low- and middle-income countries will not get access to a COVID-19 vaccine until 2024. This is a threat to people around the world, to the US, and to the entire global economy. We can address this problem by ensuring that intellectual property restrictions do not interfere with vaccine access. President Biden himself committed to share vaccine technology with other countries when asked this past summer by activist Ady Barkan. One critical way to remove barriers to vaccine access is to reverse the Trump administration’s deadly opposition to the WTO TRIPS Waiver proposal.
U.S. opposition to this waiver, a hallmark of the Trump administration’s COVID-19 failure, is a huge roadblock to efforts to produce and manufacture accessible and affordable vaccines for all. The waiver would allow for the production of generic versions of vaccines and treatments necessary to end the COVID-19 pandemic and save lives worldwide.
The people of the U.S. stand with South Africa, India, and over 100 other countries: we want President Biden to stop opposing this proposal to temporarily waive World Trade Organization (WTO) rules that protect pharmaceutical corporation profits over human health.
U.S. opposition to this waiver, a hallmark of the Trump administration’s COVID-19 failure, is a huge roadblock to efforts to produce and manufacture accessible and affordable vaccines for all. The waiver would allow for the production of generic versions of vaccines and treatments necessary to end the COVID-19 pandemic and save lives worldwide.
The people of the U.S. stand with South Africa, India, and over 100 other countries: we want President Biden to stop opposing this proposal to temporarily waive World Trade Organization (WTO) rules that protect pharmaceutical corporation profits over human health.